The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib

被引：0
|
作者：
Francesco Grossi
Erika Rijavec
Maria Giovanna Dal Bello
Carlotta Defferrari
Annalisa Brianti
Giulia Barletta
Carlo Genova
Carmelina Murolo
Maurizio Cosso
Gabriella Fontanini
Laura Boldrini
Mauro Truini
Paolo Pronzato
机构：
[1] Istituto Nazionale per la Ricerca sul Cancro,S.S. Tumori Polmonari
[2] Istituto Nazionale per la Ricerca sul Cancro,S.C. Diagnostica per immagini ed interventistica oncologica
[3] Dipartimento di Chirurgia Università di Pisa,Sezione Anatomia Patologica
[4] Istituto Nazionale per la Ricerca sul Cancro,S.C. Anatomia e Citoistologia patologica
[5] Istituto Nazionale per la Ricerca sul Cancro,S.C. Oncologia Medica A
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Non-small-cell lung cancer; Gefitinib; Erlotinib; EGFR-TKI toxicity; EGFR mutation; K-ras mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1407 / 1412
页数：5
相关论文
共 50 条
  • [1] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Grossi, Francesco
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Defferrari, Carlotta
    Brianti, Annalisa
    Barletta, Giulia
    Genova, Carlo
    Murolo, Carmelina
    Cosso, Maurizio
    Fontanini, Gabriella
    Boldrini, Laura
    Truini, Mauro
    Pronzato, Paolo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1407 - 1412
  • [2] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zheng-Tao Zhou
    Xin-Hua Xu
    Qing Wei
    Ming-qian Lu
    Jie Wang
    Cai-Hong Wen
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 1123 - 1127
  • [3] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zhou, Zheng-Tao
    Xu, Xin-Hua
    Wei, Qing
    Lu, Ming-qian
    Wang, Jie
    Wen, Cai-Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (06) : 1123 - 1127
  • [4] EFFECTIVENESS OF ERLOTINIB IN ADVANCED NON-SMALL-CELL LUNG CANCER AFTER FAILURE OF GEFITINIB
    Saito, Haruhiro
    Murakami, Shuji
    Honda, Takeshi
    Kondo, Tetsuro
    Oshita, Fumihiro
    Noda, Kazumasa
    Yamada, Kouzo
    ANNALS OF ONCOLOGY, 2010, 21 : 26 - 26
  • [5] Is erlotinib really active after failure of gefitinib in advanced non-small-cell lung cancer patients?
    Vasile, E.
    Tibaldi, C.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2009, 20 (04) : 790 - 791
  • [6] Comparison of Gefitinib and Erlotinib for Patients with Advanced Non-Small-Cell Lung Cancer
    Lee, Jin Hwa
    Lee, Kyoung Eun
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (04) : 280 - 287
  • [7] Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
    Passaro, Antonio
    Alesini, Daniele
    Pochesci, Alessia
    Cortesi, Enrico
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (05) : 646 - 650
  • [8] Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib
    Cho, Byoung Chul
    Im, Chong-Kun
    Park, Moo-Suk
    Kim, Se Kyu
    Chang, Joon
    Park, Jong Pil
    Choi, Hye Jin
    Kim, Yu Jin
    Shin, Sang-Joon
    Sohn, Joo Hyuk
    Kim, Hoguen
    Kim, Joo Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2528 - 2533
  • [9] Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancer
    Song, Zhengbo
    Yu, Xinmin
    He, Chunxiao
    Zhang, Beibei
    Zhang, Yiping
    JOURNAL OF THORACIC DISEASE, 2013, 5 (04) : 400 - 405
  • [10] Erlotinib for relapsed or refractory Non-Small-Cell Lung Cancer after failure of gefitinib
    Nishihira, Ryuichi
    Ogura, Takashi
    Tajiri, Michihiko
    Kato, Terufumi
    Sekine, Akimasa
    Shinohara, Takeshi
    Baba, Tomohisa
    Takahashi, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S703 - S703
12345